Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canada Postdoctoral Research Award (CPRA) program

Direct Payment

$140,000.00

The over-expression of KCNK4 via AAV9 for pain treatment in older individuals

EF 2025-26

Résumé
Chronic pain affects nearly 8 million Canadians, a third of them with impairment of function. It has a net annual cost of more than $40 billion. The impact of pain is even more significant in older individuals, who are plagued by a greater prevalence of pain conditions but receive fewer and less aggressive treatments, in part because drug-drug interactions and comorbidities that leave them more vulnerable to side effects. Whereas the majority of pain complaints are specific to one location, most pain treatments are systemic and are more likely to cause adverse effects. We propose a novel adeno-associated virus (AAV)-based approach to increase potassium channel expression in pain-sensing neurons using location and cell type precision to reduce pain while minimizing potential side effects. We have shown the success of the AAV approach in mice less than 12 weeks old (young mice) and will now pursue this strategy in male and female 18-month-old or aged mice. Both young and aged male and female mice will receive a nerve injury called a spared nerve injury (SNI) along with an AAV injection directly into the injured nerve. Through behavioural assessments, we will evaluate the effectiveness of the AAVs in these mice. Histology of the neuron cell bodies located in the dorsal root ganglia (DRG) will be performed to determine which neuronal populations are being infected, or transduced, by the AAV. Analysis of the protein and RNA of the injured and naïve AAV-infected DRG will also be completed. Due to the prominent role a population of immune cells called microglia plays in SNI pain, the activation and proliferation of microglia will be initially evaluated using histology. They will then be purified from the spinal cord for RNA sequencing to better understand how damaged neurons and microglia interact. Through this work, I hope to not only develop more effective pain treatment options but also better understand how sex and age alter pain development and maintenance.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
537486
Name
Bannerman Courtney A
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
The over-expression of KCNK4 via AAV9 for pain treatment in older individuals
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Adeno-Associated Virus; Aging; Dorsal Root Ganglia; Microglia; Pain; Potassium Channels; Proteomics; Sensory Neurons; Spinal Cord; Transcriptomics
Abstract
Chronic pain affects nearly 8 million Canadians, a third of them with impairment of function. It has a net annual cost of more than $40 billion. The impact of pain is even more significant in older individuals, who are plagued by a greater prevalence of pain conditions but receive fewer and less aggressive treatments, in part because drug-drug interactions and comorbidities that leave them more vulnerable to side effects. Whereas the majority of pain complaints are specific to one location, most pain treatments are systemic and are more likely to cause adverse effects. We propose a novel adeno-associated virus (AAV)-based approach to increase potassium channel expression in pain-sensing neurons using location and cell type precision to reduce pain while minimizing potential side effects. We have shown the success of the AAV approach in mice less than 12 weeks old (young mice) and will now pursue this strategy in male and female 18-month-old or aged mice. Both young and aged male and female mice will receive a nerve injury called a spared nerve injury (SNI) along with an AAV injection directly into the injured nerve. Through behavioural assessments, we will evaluate the effectiveness of the AAVs in these mice. Histology of the neuron cell bodies located in the dorsal root ganglia (DRG) will be performed to determine which neuronal populations are being infected, or transduced, by the AAV. Analysis of the protein and RNA of the injured and naïve AAV-infected DRG will also be completed. Due to the prominent role a population of immune cells called microglia plays in SNI pain, the activation and proliferation of microglia will be initially evaluated using histology. They will then be purified from the spinal cord for RNA sequencing to better understand how damaged neurons and microglia interact. Through this work, I hope to not only develop more effective pain treatment options but also better understand how sex and age alter pain development and maintenance.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Bannerman, Courtney A
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~